Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production

被引:47
作者
Chen, Li [1 ]
Frister, Adrian [1 ]
Wang, Song [1 ]
Ludwig, Andreas [2 ]
Behr, Hagen [1 ]
Pippig, Susanna [1 ]
Li, Beibei [1 ]
Simm, Andreas
Hofmann, Britt [3 ]
Pilowski, Claudia [1 ]
Koch, Susanne [1 ]
Buerke, Michael [1 ]
Rose-John, Stefan [4 ]
Werdan, Karl [1 ]
Loppnow, Harald [1 ]
机构
[1] Univ Halle Wittenberg, Univ Klin & Poliklin Innere Med 3, D-06097 Halle, Saale, Germany
[2] Univ Klinikum Aachen, Inst Pharmakol & Toxikol, Aachen, Germany
[3] Univ Halle Wittenberg, Univ Klin & Poliklin Herz & Thoraxchirurg, D-06097 Halle, Saale, Germany
[4] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2009年 / 296卷 / 04期
关键词
inflammation; monocytes/macrophages; chemokines; cytokines; lipopolysaccharide; interleukin-6; monocyte chemoattractant protein-1; TUMOR-NECROSIS-FACTOR; NEONATAL-RAT CARDIOMYOCYTES; E-DEFICIENT MICE; NF-KAPPA-B; CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL-CELLS; REDUCES ATHEROSCLEROSIS; INTERLEUKIN-6; RECEPTOR; CHEMOTACTIC PROTEIN-1; DENDRITIC CELLS;
D O I
10.1152/ajpheart.01158.2008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chen L, Frister A, Wang S, Ludwig A, Behr H, Pippig S, Li B, Simm A, Hofmann B, Pilowski C, Koch S, Buerke M, Rose-John S, Werdan K, Loppnow H. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am J Physiol Heart Circ Physiol 296: H987-H996, 2009. First published January 23, 2009; doi:10.1152/ajpheart.01158.2008.-Inflammatory mechanisms contribute to atherogenesis. Monocyte chemoattractant protein (MCP)-1 and IL-6 are potent mediators of inflammation. Both contribute to early atherogenesis by luring monocytes and regulating cell functions in the vessel wall. MCP-1 and IL-6 production resulting from the interaction of invading monocytes with local vessel wall cells may accelerate atherosclerosis. We investigated the influence of the interaction of human vascular smooth muscle cells (SMCs) with human mononuclear cells (MNCs) or monocytes on IL-6 and MCP-1 production in a coculture model. Interaction synergistically enhanced IL-6 and MCP-1 production (up to 30- and 10-fold, respectively) compared with separately cultured cells. This enhancement was mediated by CD14-positive monocytes. It was dependent on the SMC-to-MNC/monocyte ratio, and as few as 0.2 monocytes/SMC induced the synergism. Synergistic IL-6 production was observed at the protein, mRNA, and functional level. It was mediated by soluble factors, and simultaneous inhibition of IL-1, TNF-alpha, and IL-6 completely blocked the synergism. IL-1, TNF-alpha, and IL-6 were present in the cultures. Blockade of the synergism by soluble glycoprotein 130Fc/soluble IL-6 receptor, as well as the induction of synergistic IL-6 production by costimulation of SMCs with IL-1, TNF-alpha, and hyper-IL-6, suggested the involvement of IL-6 trans-signaling. The contribution of IL-6 was consistent with enhanced STAT3 phosphorylation. The present data suggest that SMC/monocyte interactions may augment the proinflammatory status in the tissue, contributing to the acceleration of early atherogenesis.
引用
收藏
页码:H987 / H996
页数:10
相关论文
共 50 条
[1]   CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells [J].
Ancuta, Petronela ;
Wang, Jianbin ;
Gabuzda, Dana .
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (05) :1156-1164
[2]  
BACON K, 1990, Cytokine, V2, P100, DOI 10.1016/1043-4666(90)90003-C
[3]   Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line [J].
Biswas, P ;
Delfanti, F ;
Bernasconi, S ;
Mengozzi, M ;
Cota, M ;
Polentarutti, N ;
Mantovani, A ;
Lazzarin, A ;
Sozzani, S ;
Poli, G .
BLOOD, 1998, 91 (01) :258-265
[4]   Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils [J].
Chalaris, Athena ;
Rabe, Bjoern ;
Paliga, Krzysztof ;
Lange, Hans ;
Laskay, Tamas ;
Fielding, Ceri A. ;
Jones, Simon A. ;
Rose-John, Stefan ;
Scheller, Juergen .
BLOOD, 2007, 110 (06) :1748-1755
[5]   IL-6 switches the differentiation of monocytes from dendritic cells to macrophages [J].
Chomarat, P ;
Banchereau, J ;
Davoust, J ;
Palucka, AK .
NATURE IMMUNOLOGY, 2000, 1 (06) :510-514
[6]  
Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205
[7]   Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice [J].
Elhage, R ;
Clamens, S ;
Besnard, S ;
Mallat, Z ;
Tedgui, A ;
Arnal, JF ;
Maret, A ;
Bayard, F .
ATHEROSCLEROSIS, 2001, 156 (02) :315-320
[8]   Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice [J].
Gu, L ;
Okada, Y ;
Clinton, SK ;
Gerard, C ;
Sukhova, GK ;
Libby, P ;
Rollins, BJ .
MOLECULAR CELL, 1998, 2 (02) :275-281
[9]   The immune response in atherosclerosis: a double-edged sword [J].
Hansson, Goran K. ;
Libby, Peter .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (07) :508-519
[10]   Novel immunosuppressive properties of interleukin-6 in dendritic cells:: inhibition of NF-κB binding activity and CCR7 expression [J].
Hegde, S ;
Pahne, J ;
Smola-Hess, S .
FASEB JOURNAL, 2004, 18 (10) :1439-+